In oral squamous cell carcinoma, high FAK expression is correlated with low p53 expression

Virchows Archiv

Volumn 461, Issue 2, 2012, Pages 163-168

  Rosado, Pablo ^a   Lequerica Fernández, Paloma ^b   Peña, Ignacio ^c   Alonso Durán, Laura ^c   De Vicente, Juan C ^c  

^a HOSPITAL DE CABUEÑES   (Spain)

^b HOSPITAL SAN AGUSTÍN   (Spain)

^c DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

FAK; Immunohistochemistry; Oral squamous cell carcinoma; p16 INK4a; p53

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; FOCAL ADHESION KINASE; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER SURGERY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME POLYMORPHISM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; MOUTH SQUAMOUS CELL CARCINOMA; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DOWN-REGULATION; FEMALE; FOCAL ADHESION KINASE 1; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM GRADING; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 84867401795     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-012-1283-2     Document Type: Article

References (43)

1. Garcia S, Dales JP, Charafe-Jauffret E, Carpentier-Meunier S, Andrac-Meyer L, Jacquemier J, Andonian C, Lavaut MN, Allasia C, Bonnier P, Charpin C (2007) Overexpression of c-Met and of the transducers PI3K, Fak and JAK in breast carcinomas correlates with shorter survival and neoangiogenesis. Int J Oncol 31:49-58
2. Lark AL, Livasy CA, Calvo B, Caskey L, Moore DT, Yang X, Cance WG (2003) Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. Clin Cancer Res 9:215-222 (Pubitemid 36109736)
3. Itoh S, Maeda T, Shimada M, Aishima S, Shirabe K, Tanaka S, Maehara Y (2004) Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma. Clin Cancer Res 10:2812-2817 (Pubitemid 38509160)
4. Zhao J, Guan JL (2009) Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev 28:35-49
5. Miyazaki T, Kato H, Nakajima M, Sohda M, Fukai Y, Masuda N, Manda R, Fukuchi M, Tsukada K, Kuwano H (2003) Fak overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer 89:140-145 (Pubitemid 36903212)
6. Su JM, Gui L, Zhou YP, Zha XL (2002) Expression of focal adhesion kinase and alpha5 and beta1 integrins in carcinomas and its clinical significance. World J Gastroenterol 8:613-618 (Pubitemid 34918651)
7. Aronsohn MS, Brown HM, Hauptman G, Kornberg LJ (2003) Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx. Laryngoscope 113:1944-1948 (Pubitemid 37409682)
8. Hsu NY, Chen CY, Hsu CP, Lin TY, Chou MC, Chiou SH, Chow KC (2007) Prognostic significance of expression of nm23-H1 and focal adhesion kinase in non-small cell lung cancer. Oncol Rep 18:81-85
9. Judson PL, He X, Cance WG, Van Le L (1999) Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma. Cancer 86:1551-1556 (Pubitemid 29489790)
10. Rovin JD, Frierson HF Jr, Ledinh W, Parsons JT, Adams RB (2002) Expression of focal adhesion kinase in normal and pathologic human prostate tissues. Prostate 53:124-132
11. Kim SJ, Park JW, Yoon JS, Mok JO, Kim YJ, Park HK, Kim CH, Byun DW, Lee YJ, Jin SY, Suh KI, Yoo MH (2004) Increased expression of focal adhesion kinase in thyroid cancer: immunohistochemical study. J Korean Med Sci 19:710-715 (Pubitemid 39452129)
12. Zhao JH, Reiske H, Guan JL (1998) Regulation of the cell cycle by focal adhesion kinase. J Cell Biol 143:1997-2008 (Pubitemid 29022619)
13. Haskell H, Natarajan M, Hecker TP, Ding Q, Stewart J Jr, Grammer JR, Gladson CL (2003) Focal adhesion kinase is expressed in the angiogenic blood vessels of malignant astrocytic tumors in vivo and promotes capillary tube formation of brain microvascular endothelial cells. Clin Cancer Res 9:2157-2165 (Pubitemid 36687638)
14. Hauck CR, Hsia DA, Ilic D, Schlaepfer DD (2002) v-Src SH3-enhanced interaction with focal adhesion kinase at beta 1 integrincontaining invadopodia promotes cell invasion. J Biol Chem 277:12487-12490 (Pubitemid 34952603)
15. Hsia DA, Mitra SK, Hauck CR, Streblow DN, Nelson JA, Ilic D, Huang S, Li E, Nemerow GR, Leng J, Spencer KS, Cheresh DA, Schlaepfer DD (2003) Differential regulation of cell motility and invasion by FAK. J Cell Biol 160:753-767 (Pubitemid 36298270)
16. Lim ST, Chen XL, Lim Y, Hanson DA, Vo TT, Howerton K, Larocque N, Fisher SJ, Schlaepfer DD, Ilic D (2008) Nuclear Fak promotes cell proliferation and survival through FERMenhanced p53 degradation. Mol Cell 29:9-22
17. Golubovskaya VM, Finch R, Cance WG (2005) Direct interaction of the N terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53. J Biol Chem 280:25008-25021 (Pubitemid 40934593)
18. Cance WG, Golubovskaya VM (2008) Focal adhesion kinase versus p53: apoptosis or survival? Sci Signal 1: pe22
19. Friedrich RE, Giese M, Riethdorf S, Loning T (2000) P53-mutation in smears of oral squamous cell carcinoma. Anticancer Res 20:4927-4930 (Pubitemid 32319054)
20. Tandon S, Tudur-Smith C, Riley RD, Boyd MT, Jones MT (2010) A systematic review of p53 as a prognosis factor of survival in squamous cell carcinoma of the four main anatomical subsites of head and neck. Cancer Epidemiol Biomarkers Prev 19:574-587
21. Choi S, Myers JN (2008) Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 87:14-32
22. Psyrri A, DiMaio D (2008) Human papillomavirus in cervical and head-and-neck cancer. Nat Clin Pract Oncol 5:24-31 (Pubitemid 351512426)
23. Harris SL, Thorne LB, Seaman WT, Hayes DN, Couch ME, Kimple RJ (2011) Association of p16 (INK4a) overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue. Head Neck 33:1622-1627
24. Santos M, Montagut C, Mellado B, García A, Ramón y Cajal S, Cardesa A, Puig-Tintoré LM, Ordi J (2004) Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva. Int J Gynecol Pathol 23:206-214 (Pubitemid 38857109)
25. Riethdorf S, Neffen EF, Cviko A, Löning T, Crum CP, Riethdorf L (2004) p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias. Hum Pathol 35:1477-1483 (Pubitemid 40017987)
26. Thomas J, Primeaux T (2012) Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma? Ann Diagn Pathol 16:91-99
27. Klussmann JP, Gültekin E, Weissenborn SJ, Wieland U, Dries V, Dienes HP, Eckel HE, Pfister HJ, Fuchs PG (2003) Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 162:747-753 (Pubitemid 36237483)
28. Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844-847 (Pubitemid 28331029)
29. Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471-1474
30. Grabenbauer GG, Mühlfriedel CH, Rödel F, Niedobitek G, Hornung J, Rödel C, Martus P, Iro H, Kirchner T, Steininger H, Sauer R, Weidenbecher M, Distel L (2000) Squamous cell carcinoma of the oropharynx: ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 48:1041-1050
31. Sittel C, Ruiz S, Volling P, Kvasnicka HM, Jungehülsing M, Eckel HE (1999) Prognostic significance of Ki-67(MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity. Oral Oncol 35:583-589 (Pubitemid 29506985)
32. Golubovskaya V, Kaur A, Cance W (2004) Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites. Biochim Biophys Acta 1678:111-125 (Pubitemid 38626172)
33. Golubovskaya VM, Finch R, Kweh F, Massoll NA, Campbell-Thompson M, Wallace MR, Cance WG (2008) p53 regulates FAK expression in human tumor cells. Mol Carcinog 47:373-382 (Pubitemid 351614577)
34. Rodrigo JP, Cabanillas R, Secades P, Canel M, Chiara MD, Suárez C (2007) Relationship between FAK and P53 expression in squamous cell carcinomas of the larynx. Acta Otorrinolaringol Esp 58:347-351 (Pubitemid 47574131)
35. Golubovskaya VM, Conway-Dorsey K, Edmiston SN, Tse CK, Lark AA, Livasy CA, Moore D, Millikan RC, Cance WG (2009) FAK overexpression and p53 mutations are highly correlated in human breast cancer. Int J Cancer 125:1735-1738
36. Livasy CA, Moore D, Cance WG, Lininger RA (2004) Focal adhesion kinase overexpression in endometrial neoplasia. Appl Immunohistochem Mol Morphol 12:342-345 (Pubitemid 39602074)
37. Lim ST, Miller NLG, Nam JO, Chen XL, Lim Y, Schlaepfer DD (2010) Pyk2 inhibition of p53 as an adaptative and intrinsic mechanism facilitating cell proliferation and survival. J Biol Chem 285:1743-1753
38. Cohen LA, Guan JL (2005) Residues within the first subdomain of the FERM-like domain in focal adhesion kinase are important in its regulation. J Biol Chem 280:8197-8207 (Pubitemid 40349721)
39. Schlaepfer DD, Hou S, Lim ST, Tomar A, Yu H, Lim Y, Hanson DA, Uryu SA, Molina J, Mitra SK (2007) Tumor necrosis factoralpha stimulates focal adhesion kinase activity required for mitogen-activated kinase-associated interleukin 6 expression. J Biol Chem 282:17450-17459 (Pubitemid 47100318)
40. Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, Sasaki C, Joe J, Camp RL, Rimm DL, Psyrri A (2006) Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 24:736-747 (Pubitemid 46622040)
41. Kumar B, Cordell KG, Lee JS, Worden FP, Prince ME, Tran HH, Wolf GT, Urba SG, Chepeha DB, Teknos TN, Eisbruch A, Tsien CI, Taylor JM, D'Silva NJ, Yang K, Kurnit DM, Bauer JA, Bradford CR, Carey TE (2008) EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 26:3128-3137
42. Karsai S, Abel U, Roesch-Ely M, Affolter A, Hofele C, Joos S, Plinkert PK, Bosch FX (2007) Comparison of p16 (INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis. J Pathol 211:314-322 (Pubitemid 46172707)
43. Chen SF, Yu FS, Chang YC, Fu E, Nieh S, Lin YS (2012) Role of human papillomavirus infection in carcinogenesis of oral squamous cell carcinoma with evidences of prognostic association. J Oral Pathol Med 41:9-15